Kyle N. Kunze, Robert A. Burnett, Joshua Wright-Chisem, Rachel M. Frank, and Jorge Chahla
Published online – April 2020
Adipose-Derived Mesenchymal Stem Cell Treatments and Available Formulations
Abstract
Several available processing techniques and formulations for ADSCs exist with evidence to suggest benefits with the use of ADSCs, but the superiority of any one method is not clear. Evidence from the most recent clinical studies available demonstrates promising outcomes following treatment of select musculoskeletal pathologies with ADSCs despite reporting variability among ADSCs harvesting and processing; these include (1) healing benefits and pain improvement for rotator cuff and Achilles tendinopathies, (2) improvements in pain and function in those with knee and hip osteoarthritis, and (3) improved cartilage regeneration for osteochondral focal defects of the knee and talus. The limitation to most of this literature is the use of other therapeutic biologics in combination with ADSCs. Additionally, many studies lack control groups, making establishment of causation inappropriate. It is imperative to perform higher-quality studies using consistent, predictable control populations and to standardize formulations of ADSCs in these trials.
Keywords: Adipose, Stem cells, ADSCs, Biologics, Formulations, Regenerative medicine
You can find more info here.